VOICED : Argentina desarrolla suero terapéutico para tratar pacientes con covid-19

Argentinian researchers have developed a therapeutic serum that can neutralize the coronavirus in vitro. This potential treatment is entering clinical trials with 250 patients across 15 hospitals. Unlike vaccines, which take longer to develop, this serum could immediately block the virus in early-stage COVID-19 patients, preventing disease progression. The serum is produced by injecting a coronavirus protein into horses, which then generate antibodies. This method is safe for horses and allows for large-scale production. The serum's neutralizing power is significantly higher than that of convalescent plasma, marking it as the first potential COVID-19 treatment developed in Argentina through public and private collaboration.

What is the primary goal of the therapeutic serum developed by Argentinian researchers?

• To cure COVID-19 completely

• To neutralize the coronavirus in vitro

• To treat all viral infections

• To replace vaccines

How does the serum help in controlling COVID-19?

• By increasing oxygen levels

• By reducing fever

• By blocking the virus from entering cells

• By boosting the immune system

What is the serum compared to in terms of its mechanism?

• Antibiotics

• Vaccines

• Treatments for snake bites and rabies

• Painkillers

How is the serum produced?

• By synthesizing chemicals in a lab

• By using human blood samples

• By extracting antibodies from plants

• By injecting a coronavirus protein into horses

What is a significant advantage of the serum over convalescent plasma?

• It has a higher neutralizing potency

• It is easier to administer

• It is cheaper to produce

• It requires no clinical trials